← HDFC Mutual Fund

HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan

Equity Data as of Oct 2026 Comparing Sep 2026 → Oct 2026
Share: WhatsApp X
Stocks Held
38
Oct 2026
Equity Holdings
₹3,621.02 Cr
Equity only, excl. debt & cash
AAUM
₹3,097.34 Cr
Jul-Sep 2026 · Direct + Regular
Top 5 Weight
33.8%
Moderate
Top 10 Weight
51.7%
Moderate
Changes
39
1 new · 1 exits
Top Sector
Pharmaceuticals & Biotechnology
70.9% of portfolio
Launch Date
14 Sep 2023
3 years old

AAUM (Average Assets Under Management) of ₹3,097.34 Cr for Jul-Sep 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.

📋 What Happened This Month HDFC Pharma and Healthcare Fund made 1 new addition and exited 1 stock this month. The biggest new buy was Paras Healthcare Ltd. (Healthcare Services) at 2.34% weight. Cohance Lifesciences Limited was the biggest exit (Pharmaceuticals & Biotechnology), which was held at 0.32%. Among existing holdings, Dr. Reddy's Laboratories Limited saw the biggest increase — now at 6.66% of the portfolio. IPCA Laboratories Limited was trimmed the most, now at 1.93%. Divi's Laboratories Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 70.9%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.
Sector Shift Industry allocation month-over-month
Aug 2026 → Sep 2026
Sector Prev Curr ▼ Delta
Pharmaceuticals & Biotechnology 72.1% 71.3% ▼ -0.9%
Healthcare Services 24.2% 22.1% ▼ -2.0%
Healthcare Equipment & Supplies 2.2% 2.4% ▲ +0.2%
Retailing 0.0% 1.0% ▲ +1.0%
Sep 2026 → Oct 2026
Sector Prev Curr ▼ Delta
Pharmaceuticals & Biotechnology 71.3% 70.9% ▼ -0.4%
Healthcare Services 22.1% 24.8% ▲ +2.7%
Healthcare Equipment & Supplies 2.4% 2.2% ▼ -0.2%
Retailing 1.0% 0.9% ▼ -0.1%
🟢
Biggest New Buy
Paras Healthcare Ltd.
2.34% weight · Healthcare Services
🔴
Biggest Exit
Cohance Lifesciences Limited
0.32% was held · Pharmaceuticals & Biotechnology
↑
Biggest Add
Dr. Reddy's Laboratories Limited
+3.47% · now 6.66%
↓
Biggest Trim
IPCA Laboratories Limited
-1.05% · now 1.93%
🤝 Other funds also bought this month
Paras Healthcare Ltd. 19 funds
Paras Healthcare Ltd.
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH
ITI ELSS Tax Saver Fund - Direct Plan - Growth Option
Kotak Healthcare Fund - Direct Plan - Growth Option + more
👋 Other funds also exited
Cohance Lifesciences Limited 7 funds
Cohance Lifesciences Limited
Groww Nifty Smallcap 250 ETF
Shriram Flexi Cap Fund
Shriram ELSS Tax Saver Fund + more

What Changed in the Portfolio This Month?

Comparing Sep 2026 → Oct 2026

Sep 2026 → Oct 2026
🟢 1 New Entry 🔴 1 Exit ↑ 9 Increased ↓ 28 Decreased
#StockSectorWeight (Oct 2026)
1
Paras Healthcare Ltd.
₹85.72 Cr
Healthcare Services 2.34%
#StockSectorLast Weight (Sep 2026)
1
Cohance Lifesciences Limited
₹11.10 Cr
Pharmaceuticals & Biotechnology 0.32%
#StockSectorSep 2026Oct 2026Change
1
Dr. Reddy's Laboratories Limited
₹244.03 Cr
Pharmaceuticals & Biotechnology 3.19% 6.66% +3.47%
2
Apollo Hospitals Enterprise Limited
₹190.25 Cr
Healthcare Services 3.69% 5.19% +1.50%
3
Acutaas Chemicals Ltd
₹135.73 Cr
Pharmaceuticals & Biotechnology 3.18% 3.70% +0.52%
4
Rubicon Research Limited
₹98.78 Cr
Pharmaceuticals & Biotechnology 2.52% 2.69% +0.17%
5
Sai Life Sciences Limited
₹63.76 Cr
Pharmaceuticals & Biotechnology 1.58% 1.74% +0.16%
6
Alkem Laboratories Limited
₹173.98 Cr
Pharmaceuticals & Biotechnology 4.64% 4.75% +0.11%
7
Divi's Laboratories Limited
₹345.91 Cr
Pharmaceuticals & Biotechnology 9.39% 9.44% +0.05%
8
Zydus Lifesciences Limited
₹68.37 Cr
Pharmaceuticals & Biotechnology 1.82% 1.86% +0.04%
9
Symbiotec Pharmalab Limited
₹50.46 Cr
Pharmaceuticals & Biotechnology 1.36% 1.38% +0.02%
#StockSectorSep 2026Oct 2026Change
1
IPCA Laboratories Limited
₹70.69 Cr
Pharmaceuticals & Biotechnology 2.98% 1.93% -1.05%
2
Gland Pharma Limited
₹38.57 Cr
Pharmaceuticals & Biotechnology 1.78% 1.05% -0.73%
3
Sun Pharmaceutical Industries Limited
₹283.56 Cr
Pharmaceuticals & Biotechnology 8.28% 7.74% -0.54%
4
Shilpa Medicare Ltd
₹107.10 Cr
Pharmaceuticals & Biotechnology 3.23% 2.92% -0.31%
5
Torrent Pharmaceuticals Limited
₹122.94 Cr
Pharmaceuticals & Biotechnology 3.65% 3.35% -0.30%
6
Neuland Laboratories Limited
₹108.38 Cr
Pharmaceuticals & Biotechnology 3.24% 2.96% -0.28%
7
Anthem Biosciences Limited
₹107.05 Cr
Pharmaceuticals & Biotechnology 3.17% 2.92% -0.25%
8
Wockhardt Limited
₹53.85 Cr
Pharmaceuticals & Biotechnology 1.71% 1.47% -0.24%
9
Krishna Institute Of Medical Sciences Limited
₹69.10 Cr
Healthcare Services 2.10% 1.89% -0.21%
10
Lupin Limited
₹122.97 Cr
Pharmaceuticals & Biotechnology 3.55% 3.35% -0.20%

What Stocks Does This Fund Hold?

38 stocks — Oct 2026

# Stock Sector Cap Weight & Value
1
₹345.91 Cr
Pharmaceuticals & Biotechnology
9.44%
2
₹283.56 Cr
Pharmaceuticals & Biotechnology
7.74%
3
₹244.03 Cr
Pharmaceuticals & Biotechnology
6.66%
4
₹190.25 Cr
Healthcare Services
5.19%
5
₹173.98 Cr
Pharmaceuticals & Biotechnology
4.75%
6
₹148.93 Cr
Pharmaceuticals & Biotechnology
4.06%
7
₹135.73 Cr
Pharmaceuticals & Biotechnology
3.70%
8
₹126.13 Cr
Healthcare Services
3.44%
9
₹123.37 Cr
Healthcare Services
3.37%
10
₹122.94 Cr
Pharmaceuticals & Biotechnology
3.35%
🏆 Top stocks held by Equity funds
See which stocks all active Equity fund managers are buying — ranked by total value invested
→
🏦 HDFC Mutual Fund — Portfolio & Holdings
See all funds managed by HDFC Mutual Fund — conviction stocks, monthly entries & exits
→

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.